Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

eGen LLC provided microfin technology based power generation systems. Its microfin technology enables to harvest energy from flowing waters such as rivers and streams. The company was founded by Frank Gerlando and Joel Sterling Douglas and was headquartered in Canton, CT.

Layton BioScience

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

EGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient delivery systems to be used to create products for treatment of human diseases. Their synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking.

Guangzhou Chenxin Pharmaceutical Technology Co., Ltd., established on 2009-05-06, Business scope includes drug research and development;Medical Research and Experimental Development;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Circuit Therapeutics, Inc. provides therapy and health care services. It specializes in optogenetics, gene therapy, neuromodulation and drug discovery services. The company was founded by Karl Deisseroth, Rob Malenka, Scott Delp, Thomas Sudhof and Karoly Nikolich and is headquartered in Menlo Park, CA.

Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI.

Nanjing Zhongkai Biomedical Technology Co., Ltd., established on 2021-09-27, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;pharmaceutical production;Drug retail;Drug Wholesale(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;hospital management;Organize cultural and artistic exchange activities;Machinery sales;Healthy food(prepackaged)Sales;Sales of formula food for special medical purposes;Food Additive Sales;Daily necessities sales;Sales of daily chemical products;Sales of hygiene products and single-use medical products;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Health Consulting Services(Does not include medical services);Cosmetics Retail;Educational Consulting Services(Education and training activities that do not include licensing approval);food sales(Only sell prepackaged food);Health Care Services(non-medical);General merchandise sales;Home Appliance Sales;glasses sales(Contact lenses not included);Disinfectant sales(Free of Hazardous Chemicals);internet sales(Except for products that require a license for sale);Mirror and similar processing;Retailing of computer software, hardware and auxiliary equipment;electronics sales;Instrument sales;Office Supplies Sales;Conference and Exhibition Services;Manufacturing of bio-based materials;Sales of bio-based materials(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation.

Part of GSK Plc, Beecham Group Plc is a British company located in Middlesex. The firm functions as an investment holding company. It was founded in 1928.\nThe company says this about itself: The principal activity Of the Company is the holding of Intercompany bans and receipt Of interest. The Company had previously been an investment holding company. The Company is a member Of the GlaxoSmithKline Group (the 'Group\"). The directors do not envisage any change to the nature of the business in the future,